Bleeding complications in acute liver failure
Authors:
- R. Todd StravitzRSR. Todd Stravitz
- William M. LeeWLWilliam M. Lee
- the Acute Liver Failure Study GroupTGthe Acute Liver Failure Study Group
- 1 December 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 67 (5) , 1931-1942
Abstract
In patients with acute liver failure (ALF), elevated prothrombin time and thrombocytopenia can fuel a perception of a bleeding tendency. However, the incidence, site, risk factors, and clinical significance of bleeding complications have not been quantified in a large cohort of patients with ALF. We studied 1,770 adult patients enrolled in the ALF Study Group Registry between 1998 and 2016. Bleeding complications and blood component transfusions were collected for 7 days after admission. The relationship of bleeding complications to 21‐day mortality was assessed. Despite a median international normalized ratio of 2.7 and platelet count of 96 × 109/L on admission, bleeding complications were observed in only 187 patients (11%), including 173 spontaneous and 22 postprocedural bleeding episodes. Eighty‐four percent of spontaneous bleeding episodes were from an upper gastrointestinal source and rarely resulted in red blood cell transfusion. Twenty patients experienced an intracranial bleed; half of these occurred spontaneously and half after intracranial pressure monitor placement, and this was the proximate cause of death in 20% and 50%, respectively. Bleeders and patients who received red blood cell transfusions were more acutely ill from extrahepatic organ system failure but not from hepatocellular failure. Consistent with this observation, bleeding complications were associated with lower platelet counts but not higher international normalized ratio. Transfusion of any blood component was associated with nearly 2‐fold increased death or need for liver transplantation at day 21, but bleeding complications were the proximate cause of death in only 5% of cases. Conclusions. Despite a perceived bleeding diathesis, clinically significant bleeding is uncommon in patients with ALF; bleeding complications in patients with ALF are markers of severe systemic inflammation rather than of coagulopathy and so portend a poor prognosis. (Hepatology 2018;67:1931‐1942)Keywords
Funding Information
- National Institutes of Health (U‐01 58369)
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 28 references indexed in Scilit:
- Outcomes in Adults With Acute Liver Failure Between 1998 and 2013Annals of Internal Medicine, 2016
- Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patientsIntensive Care Medicine, 2015
- An Unbalance Between von Willebrand Factor and ADAMTS13 in Acute Liver Failure: Implications for Hemostasis and Clinical OutcomeHepatology, 2013
- Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failureJournal of Thrombosis and Haemostasis, 2012
- Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastographyJournal of Hepatology, 2012
- Gastric Mucosal Defense and Cytoprotection: Bench to BedsideGastroenterology, 2008
- Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxisIntensive Care Medicine, 2003
- Central venous cannulation in patients with liver disease and coagulopathy - a prospective auditIntensive Care Medicine, 1999
- Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage.1975
- The treatment of acute liver failure.1972